EC
RNAC icon

EcoR1 Capital’s Cartesian Therapeutics RNAC Stock Holding History

EcoR1 Capital’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6,667
Closed -$278K – 64
2023
Q1 		$278K Sell
6,667
-110,000
-94% -$5.17M 0.01% 54
2022
Q4 		$3.96M Hold
116,667
– – 0.12% 49
2022
Q3 		$5.74M Hold
116,667
– – 0.17% 45
2022
Q2 		$4.58M Buy
+116,667
New +$3.46M 0.16% 49
2020
Q2 		– Sell
-153,257
Closed -$11.1M – 64
2020
Q1 		$11.1M Hold
153,257
– – 1.16% 25
2019
Q4 		$10.9M Buy
+153,257
New +$7.39M 1.04% 24

Other funds holding RNAC

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $581M AUM 108.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return